Fibromyalgia is a clinical syndrome wherein the patient experiences generalized pain and fatigue that cannot be explained by the presence of any other disorder.
It is often considered to be psychosomatic or psychogenic in nature.
It is found in approximately 2% of the population and the prevalence increases with age, most common in women 20-55 year of age

Fibromyalgia Patient Education

Patient Education

  • Critical in the optimal management of fibromyalgia
  • Goal is to help the patient understand and manage the symptoms optimally, reduce dependence on the medical system and work effectively within the system
  • Provide patient and family with information about fibromyalgia, diagnosis and all treatment options
  • It should be emphasized that fibromyalgia is a real disease and is not a deforming or a deteriorating disorder
    • Great majority of patients have normal and active lives
    • Discuss the patient's adherence or nonadherence to the agreed upon treatment strategies and other modalities
    • Confirm the diagnosis in an authoritative manner and reassure patients that they can be helped
  • Emphasize the role of stress and mood disorder, encourage fibromyalgia patients to learn simple relaxation techniques and to consider formal stress-reduction programs
  • Reinforce the importance of proper sleep hygiene
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.